Why Fred’s, Inc. (FRED) 5% on 09/08/17?

Fred’s, Inc. (FRED) jumped 5% as a result of Bullish news signal:

Fred’s Inc. today reported financial results for the second quarter and six months ended July 29, 2017.

For the second quarter ended July 29, 2017, Fred’s recorded a net loss of approximately $29.5 million or $0.78 per share, which included the following charges totaling $30.1 million, or $0.63 per share after tax:

  • $11.3 million or $0.30 per share after tax for a valuation allowance against the Company’s deferred tax asset resulting from the pretax loss recorded during the second quarter;
  • $15.2 million or $0.26 per share after tax for bank fees, financing termination fees, prior period deferred expenses recognized in the current quarter for certain contract terminations and amendments, and other professional and legal advisory fees incurred in connection with the proposed acquisition of Rite Aid stores; the development and implementation of the Company’s growth strategy; and other professional and legal advisory fees;
  • $2.8 million or $0.05 per share after tax for asset impairments and other expenses pertaining to the planned closure of 13 stores and certain pharmacy departments, as part of Fred’s ongoing asset management of its overall chain; and
  • $0.8 million or $0.02 per share after tax for other non-recurring charges.

Net sales for the second quarter were $507.8 million, down 4.1% from $529.5 million in the same period last year. Comparable store sales for the second quarter declined 0.3% versus a decrease of 2.0% in the second quarter last year. Comparable store sales in the second quarter of 2017 included a negative 0.8% impact as a result of the sale of low productive discontinued inventory versus the second quarter of 2016.

Gross profit for the second quarter of 2017 decreased to $126.0 million from $128.1 million in the prior-year period, primarily explained by a decrease in sales resulting from the closure of 39 underperforming stores. Gross profit margin for the quarter increased 60 basis points to 24.8% from 24.2% in the same quarter last year, reflecting the benefit of key turnaround initiatives intended to drive profitability and cash flow.

Fred’s recorded a LIFO reserve reduction of $0.3 million in the second quarter of 2017 compared with an increase of $0.2 million in the same quarter last year.

finviz dynamic chart for  fred

First Six Months Ended July 29, 2017

For the first six months ended July 29, 2017, Fred’s recorded a net loss of approximately $66.0 million or $1.76 per share, which included the following charges totaling $75.0 million, or $1.55 per share after tax:

  • $25.8 million or $0.69 per share after tax for a valuation allowance against the Company’s deferred tax asset resulting from the pretax loss created primarily by the following charges in the first six months of 2017;
  • $32.1 million or $0.55 per share after tax for bank fees, financing termination fees, other professional and legal advisory fees incurred in connection with the proposed acquisition of Rite Aid stores and the development and implementation of the Company’s growth strategy;
  • $16.3 million or $0.29 per share after tax for lease liability impairment, asset impairments and other expenses pertaining to the closure of 39 underperforming stores and the planned closure of 13 stores and certain pharmacy departments, as part of Fred’s ongoing asset management of its overall chain; and
  • $0.8 million or $0.02 per share after tax for other non-recurring charges.

“Our Retail Pharmacy business continues to improve, delivering flat comp scripts year-to-date adjusted for 90 days, and increases in our Generic Dispensing Rate and our overall gross profit dollars per script. In Specialty Pharmacy, we continue to drive sales growth through geographic expansion into new markets and diversification within our existing therapies. Despite ongoing headwinds in Consumables in the Front Store, we experienced a 60 basis point improvement in comparable sales in our General Merchandise division over the same quarter last year.”

 

Business Wire 

Explanation:

Why Bullish? its Retail and Specialty Pharmacy businesses are improving significantly, and the momentum is likely to continue throughout fiscal 2017.  The stock has been impacted by the bullish news and jumped by 5%. It is very common that these type of news (i.e. strong financial results) will impact the stock in a bullish manner. Therefore, we provide this stock a  short-term bullish signal

Latest price: 6.8

Entry level: 6.79

Exit level: 7.2

Stop level: 6.4

  Jordan Mizrahi

(Views and recommendations given in this section are for research purpose only. Please consult your financial adviser before taking any position in the stock/s mentioned.) Neither First to invest. nor any of its officers, employees, representatives, agents or independent contractors are, in such capacities, licensed financial advisors, registered investment advisers or registered broker-dealers. First to invest does not provide investment or financial advice or make investment recommendations. Nothing contained in this communication constitutes a solicitation, recommendation, promotion, endorsement or offer by First to invest of any particular security, transaction or investment. Our goal as publishers of financial information is to provide research and analysis of investments to our subscribers

Stock bullish and bearish news signals will make you better trader

Providing stock news signals and monitoring service based on big data and text analysis of bullish and bearish news such as new buyout deal, FDA announcement, clinical trial results, new product/service, a joint venture agreement, new orders, sales numbers, financial results, analyst recommendation etc… Therefore, by utilizing the power of bullish and bearish news signals into your investments, you will dramatically improve results on profits more than any other investment techniques. We are the only company that produces investment signals (i.e. stock recommendation including entry, exit and stop levels for each recommendation) based on stock’s bullish and bearish news.

We use in-house crawl software to aggregate more than 5,000 stock news from 100’s data sources each day and use big data to arrange the news to sectors such: technology, pharma, bio tech, energy, retail etc… and text analysis to analyze the data… You will be received signals including entry, exit and stop levels premarket and during the trading hours.

 

Why register for a First To Invest PRO monthly subscription?

  • You will get 10 daily bullish and bearish stock news signals that moves prices in the short and long term

  • You can ask for online news signals on interested stocks via live chat before and during trading hours

  • Save you time by reading and analyzing 5,000 stock news from more than 100’s of data sources for you

  • We believe in our ability to generate you profits. That’s why we offer monthly subscription with no commitment and with full money-back guarantee in your first quarter of subscription

TRY OUR STOCK NEWS SIGNALS FOR $18

 

What is First to invest Pro subscription?
First to invest provides stock news signals for short and long term investments for one flat monthly fee. We are the only company that produces investment signals (i.e. stock recommendation including entry, exit and stop levels for each recommendation) based on stock’s bullish and bearish news.

What’s included in Pro subscription?
You’ll receive 10 daily pre-market and intra-day bullish and bearish news signals that can impact the price in the short and long term. For example:

“Stock Bullish short-term news signal:

  • Lululemon Athletica Inc. (LULU): Lululemon beats Street 2Q forecasts. Read More

Why Bullish? For the current quarter ending in November, Lululemon expects its per-share earnings to range from 50 cents to 52 cents. Therefore, will impact the stock in today trade and up to 2-14

Latest price: 57.55
Entry level: 60.48
Exit level: 64.2
Stop level: 59.7
About the company
lululemon athletica inc., an athletic apparel company, together with its subsidiaries, designs, distributes, and retails athletic apparel and accessories for women, men, and female youth”

“Stock Bullish long-term news signal:

  • ImmunoGen, Inc. (IMGN): Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products. Read More

Why Bullish? As part of the agreement, Jazz will pay ImmunoGen an upfront payment of $75 million. Additionally, Jazz will pay ImmunoGen up to $100 million in development funding over seven years to support the three ADC programs. Therefore, will impact the stock in today trade and in the long-term

Latest price: 6.46
Entry level: 6.8
Exit level: 7.3
Stop level: 6.2
About the company
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology”

“Stock Bearish Long-term news signal:

  • Ambarella Follows a Strong Quarter With Disappointing Guidance (Again) Read more

Why Bearish? Ambarella continued to see declines in shipments for the drone market, driven by both timing of new product launches and ongoing weakness from Tier 2 drone customers. Therefore, will impact the stock in today trade and between 2-14 days

Latest price: 45.37
Entry level: 43.1
Exit level: 46.2
Stop level: 41.9

About the company
Ambarella, Inc. develops semiconductor processing solutions for video that enable high-definition (HD) video capture, sharing, and display worldwide”

In addition, you’ll get a daily news balancing report for sensitivity analysis for 5 stocks.

Which stock markets First to invest cover?
First to invest covers the US stocks markets at this moment with an ambition to expand into EU and Japan markets.

How will First to invest subscription help me invest more fast and accurately?
With your monthly subscription to First to invest, you’ll be able to invest in real time on stocks that are influenced by news, whether if it’s new deal, FDA approval, M&A, new product, profit announcements and analyst recommendation. When using our service, you will gain the power of 100 data sources that generate more than 5,000 stock news and analyze by our staff in order to find you the best opportunities in the market.

When do the stock news signals get delivered?
Between 30-60 minutes before the market opens and during the trade until the closing time

How the stock news signals delivered?
With your subscription to First to invest Pro, you can choose to receive our signals by Email and / or WhatsApp.

How much does First to invest cost?
The price will be $70 per month with no commitment. You can test our service by starting with “Get to know us for a 9 days” for just $18 one-time special price.

What payment methods are accepted by First to invest?
First to invest accepts all major credit cards (Visa, MasterCard, American Express, Discover and Diners Club), via PayPal. (You don’t need a PayPal account)

What is the refund policy for First to invest PRO subscription?
If you are in any way unsatisfied with First to invest Pro monthly subscription during the first quarter of your subscription, we’ll provide you with a full refund, no questions asked.

[powr-plan-comparison id=6c6f0869_1473077432]

Tell us which person will also like our service and we'll give you both one week trial for your assistance

 

Verification